Диссертация (Иммуноморфологические ассоциации инфекции helicobacter pylori с показателями воспаления и дисфункции эндотелия в оценке течения и прогноза ишемической болезни сердца), страница 73

Chevrier, Z. Guoet all // Nat. Immunol. – 2006. – N 7. – P. 868-74.557. Urbich С. Endothelial progenitor cells: characterization and role in vascular biology / С. Urbich, S. Dimmeler // Circ. Res. – 2004. – Vol. 95, N 4. – P. 343-53.558. Uyemura K. Cross regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis / K. Uyemura, K. Demer, S.C. Castle et all // J. Clin. Invest. – 1996.

– N 97. –P. 2130-38.559. Van der Wall A.C. Inflammatory activity in clinically stable and unstable atherosclerotic plaques / A.C. Van der Wall, K.T. Koch, J.J. Pick, A.E. Becker // Eur.Heart J. – 1994. – N 15. – P. 426-31.411560. Van Wetering S.

VCAM-1-mediated Rac signaling controls endothelial cell-cellcontacts and leukocyte transmigration / S. Van Wetering, N. van den Berk, J.D. vanBuul et all // Am. J. Physiol. Cell Physiol. – 2003. – Vol. 285, N 2. – P. C343-52.561. Vanderlaan P.A. Thematic review series: the immune system and atherogenesis.The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis / P.A. Vanderlaan, C.A. Readon // J.

Lipid. Res. – 2005. – Vol. 46, N 5. – P.829-38.562. Vanhoutte P.M. Endothelial control of vasomotor function: from health to coronary disease / P.M. Vanhoutte // Circ. J. – 2003. – N 67. – P. 572-75.563. Vaughan D.E. Effects of ramipril on plasma fibrinolytic balance in patients withacute anterior myocardial infarction / D.E. Vaughan, J-L. Rouleau, P.M. Ridker etall // Circulation. – 1997.

– N 96. – P. 442-47.564. Vcev A. Helicobacter pylori infection and coronary artery disease / A. Vcev, D.Nakić, A. Mrden et all // Coll. Antropol. – 2007. – Vol. 31, N 3. – P. 757-60.565. Vercellino M. The immune system in atherosclerosis and in acute myocardial infarction / M. Vercellino, P. Fabbi, M. Fedele, F. Indiveri, A. Barsotti // Heart International. – 2006. – Vol. 2, N 3-4. – P. 129-135.566. Viemann D.

MRP8/MRP14 impairs endothelial integrity and induces a caspasedependent and -independent cell death program / D. Viemann, K. Barczyk, T. Voglet all // Blood. – 2007. – N 109. – P. 2453-60.567. Viola A. Chemokines and their receptors: drug targets in immunity and inflammation / A.

Viola, A.D. Luster // Annu. Rev. Pharmacol. Toxicol. – 2008. – N 48. – P.171-97.568. Vivas J.R. Interferon gamma-signature transcript profiling and IL-23 upregulationin response to Helicobacter pylori infection / J.R. Vivas, B. Regnault, V. Michel etall // Int. J. Immunopathol. Pharmacol. – 2008. – N 21. – P. 515-26.569. Vogl T. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock / T. Vogl, K. Tenbrock, S.

Ludwig et all //Nat. Med. – 2007. – N 13. – P. 1042-49.412570. Weel J.F. The interrelationship between cytotoxin-associated gene A, vacuolatingcytotoxin, and Helicobacter pylori-related diseases / J.F.Weel, R.W.van der Hulst,Y. Gerritis et all // J. Infect. Dis. – 1996. – N 173. – P. 1171-75.571. Weiss D.

Angiotensin II and atherosclerosis / D. Weiss, D. Sorescu, W.R. Taylor //Am. J. Card. – 2001. – Vol. 87, N 8. – P. 25-32.572. Welch G.N. Homocysteine and atherothrombosis / G.N. Welch, J. Loscalzo // NewEngl. J. Med. – 1998. – Vol. 338, N 15.

– P. 1042-50.573. Weyand C.M. T cells in arteritis and atherosclerosis / C.M. Weyand, B.R. Younge,J.J. Goronzy // Curr. Opin. Lipidol. – 2008. – N 19. – P. 469-77.574. Whincup P. Prospective study of potentially virulent strains of Helicobacter pyloriand coronary heart disease in middle-aged men / P. Whincup, J. Danesh, M. Walkeret all // Circulation.

– 2000. – Vol. 101, N 14. – P. 1647-52.575. Wierzbicki A.S. Homocysteine and cardiovascular disease: a review of the evidence / A.S. Wierzbicki // Diab. Vasc. Dis. Res. – 2007. – Vol. 4, N 2. – P. 143-50.576. Wilcox J.N. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque / J.N. Wilcox, K.M. Smith, S.M. Schwartz, D.

Gordon // Proc.Natl. Acad. Sci. USA. – 1989. – N 86. – P. 2839-43.577. Witkowska A.M. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview / A.M. Witkowska, M.H. Borawska // Eur. Cytokine Netw. – 2004. – Vol. 15,N 2. – P. 91-98.578. Wyrobiec G. Ischemic heart disease and chronic Helicobacter pylori infection present views / G.

Wyrobiec, K. Helewski, M. Stepien // Wiad Lek. – 2001. – Vol.54, N 11-12. – P. 684-92.579. Xu Q. Role of heat shock protein in atherosclerosis / Q. Xu // Arterioscler.Thromb. Vasc. Biol. – 2002. – N 22. – P. 1547-49.580. Yakoob J. Helicobacter pylori: association with gall bladder disorders in Pakistan /J. Yakoob, M.R. Khan, Z. Abbas et all // Br. J. Biomed. Sci.

– 2011. – Vol. 68, N 2.– P. 59-64.413581. Yamamoto M. Alternate mucosal immune system: organized Peyer's patches arenot required for IgA responses in the gastrointestinal tract / M. Yamamoto, P.Rennert, J.R. McGhee, M.N. Kweon et all // J. Immunol. – 2000. – N 164. – P.5184-91.582. Yamamoto T. Role of tumor necrosis factor-alpha and interferon-gamma inHelicobacter pylori infection / T.

Yamamoto, M. Kita, T. Ohno et all // Microbiol.Immunol. – 2004. – N 48. – P. 647-54.583. Yamaoka J. Induction of various cytokines and development of severe mucosal inflammation by cag A gene positive Helicobacter pylori strains / T. Yamamoto, M.Kita // Gut. – 1997. – Vol.

41, N 4. – P. 442-51.584. Yamauchi K. Regulation of IL-18 in Helicobacter pylori infection / K. Yamauchi,I.J. Choi, H. Lu, H. Ogiwara, D.Y. Graham, Y. Yamaoka // J. Immunol. – 2008. – N180. – P. 1207-16.585. Ye G. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells / G. Ye, C.

Barrera, X. Fan et all // J. Clin. Invest. – 1997. – Vol. 99, N7. – P. 1628-36.586. Yi-Hong Wu. In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression / Wu Yi-Hong, Chuang Shih-Yi, Hong Wei-Chin et all // Journal ofEthnopharmacology. – 2012. – Vol. 140, N 1. – P. 55-63.587. Yla-Herttuala S. Role of lipid and lipoprotein oxidation in the pathogenesis of atherosclerosis / S.

Yla-Herttuala // Drugs Today. – 1994. – N 30. – P. 507-14.588. Yusuf S.W. Effect of Helicobacter pylori infection on fibrinogen level in elderlypatients with ischemic heart disease / S.W. Yusuf, R.M. Mishra // Acta Cardiol. –2002. – Vol. 57, N 5. – P. 317-22.589. Zarbock A. Neutrophil adhesion and activation under flow / A. Zarbock, K. Ley //Microcirculation. – 2009.

– Vol. 16, N 1. – P. 31-42.414590. ZarbockA.Leukocyteligandsforendothelialselectins:specializedglycoconjugates that mediate rolling and signaling under flow / A. Zarbock, K. Ley,R.P. McEver, A. Hidalgo // Blood. – 2011. – Vol. 118, N 26. – P. 6743-51.591. Zarbock A. PSGL-1-dependent myeloid leukocyte activation / A.

Zarbock, H.Müller, Y. Kuwano, K. Ley // J. Leukoc. Biol. – 2009. – Vol. 86, N 5. – P. 1119-24.592. Zentillin P. Eradication of Helicobacter pylori may reduce disease severity inrheumatoid arthritis / P. Zentillin, B. Seriolo, P. Dulbecco et all // AlimentaryPharmacology and Therapeutics. – 2002. – Vol.

16, N 7. – P. 1291-99.593. Zhang S. Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacterpylori and atherosclerotic diseases: a systematic review / S. Zhang, Y. Guo, Y. Ma,Y. Teng // Chin. Med. J. – 2008. – Vol. 121, N 10. – P. 946-51.594. Zhou X. Hypercholesterolemia is associated with Th1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice / X. Zhou, G. Paulsson, S.Stemme, G.K. Hansson // J. Clin.

Invest. – 1998. – N 101. – P. 1717-25.595. ZhouY.J. Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis / Y.J. Zhou, J.H. Wang, J. Zhang //Biochemical and Biophysical Research Communications. – 2006. – Vol. 344, N 2. –P. 658-66.596. Zhu J.

Lack of association of Helicobacter pylori infection with coronary arterydisease and frequency of acute myocardial infarction or death / J. Zhu, A.A.Quyyumi, J.B. Muhlestein, F.J. Nieto et all // Am. J. Cardiol. – 2002. – Vol. 89, N 2.– P. 155-58.597. Zhu X. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction / X. Zhu,A. Bagchi, H. Zhao et all // Crit.

Care Med. – 2007. – Vol. 35, N 3. – P. 886-92.598. Zhu Y.L. Biological activity of the virulence factor CagA of Helicobacter pylori /Y.L. Zhu, S. Zheng, K.D. Qian, P.C. Fang // Chin. Med. J. – 2004. – N 117. – P.1330-33..